Skip to main content
OpenTrials

Clinical trial condition

Smoldering Multiple Myeloma

Explore clinical trials studying Smoldering Multiple Myeloma. Study availability and eligibility vary by location and protocol.

77 public trials 28 recruiting studies

Smoldering Multiple Myeloma trial results

NCT03616483

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
Conditions
Amyloidosis, Blood Protein Disorders, Hematologic Diseases, +15 more
Locations
  • University of Alabama Hospital Birmingham, Alabama, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Cleveland Clinic Florida, Weston Hospital Weston, Florida, United States
View all 13 locations

NCT06895291

Conditions
Advanced Breast Cancer, Advanced Prostate Cancer, Blood Protein Disorders, +20 more
Locations
  • IRCCS - Azienda Ospedaliero-Universitaria di Bologna - Policlinico di S. Orsola Bologna, BO, Italy
  • IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l. Meldola, FC, Italy
  • IRCCS Istituto Europeo di Oncologia S.r.l. Milan, MI, Italy
Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Helsinki University Hospital Helsinki, Finland
  • CHD Vendée La Roche-sur-Yon, France
  • CHRU de Lille - Hopital Claude Huriez Lille, France
  • CHU Saint Eloi Département d'Hématologie Clinique Montpellier, France
View all 25 locations